Literature DB >> 1329795

Characterization of a cell line derived from a human oligodendroglioma.

G R Post1, G Dawson.   

Abstract

A novel clonal cell line derived from a human glioma (HOG) was found to express some oligodendrocyte-specific proteins including a 15-kDa form of myelin basic protein (MBP) and high 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) activity. Expression of the myelin lipids galactosylceramide and sulfogalactosylceramide (sulfatide) was low. HOG cells did not express the characteristic astrocyte markers glial fibrillary acidic protein (GFAP) or significant glutamine synthetase (GS) activity. After initial plating, HOG cells were flat and epitheloid and thus showed a limited oligodendrocyte-like morphology. However, after cells became more confluent, some cells were phase-bright and elaborated short processes. Receptor types expressed by HOG cells included A2-adenosine, prostaglandin E1 (PGE1), and beta 2-adrenergic receptors (beta-ARs) linked to stimulation of adenylate cyclase, and muscarinic cholinergic and H1-histamine coupled to phosphatidyinositol turnover (Post and Dawson, 1991). HOG cells should therefore provide a useful model for studying the extracellular regulation and phosphorylation of oligodendrocyte-specific proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329795     DOI: 10.1007/bf03159976

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  36 in total

1.  SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells.

Authors:  Li-Jin Chew; Weiping Shen; Xiaotian Ming; Vladimir V Senatorov; Hui-Ling Chen; Ying Cheng; Elim Hong; Susan Knoblach; Vittorio Gallo
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  Oligodendroglioma cell lines containing t(1;19)(q10;p10).

Authors:  John J P Kelly; Michael D Blough; Owen D M Stechishin; Jennifer A W Chan; Desiree Beauchamp; Marco Perizzolo; Doug J Demetrick; Lisa Steele; Roland N Auer; Walter J Hader; Morgan Westgate; Ian F Parney; Robert Jenkins; J Gregory Cairncross; Samuel Weiss
Journal:  Neuro Oncol       Date:  2010-04-13       Impact factor: 12.300

3.  Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation.

Authors:  Rui Yang; Lee H Chen; Landon J Hansen; Austin B Carpenter; Casey J Moure; Heng Liu; Christopher J Pirozzi; Bill H Diplas; Matthew S Waitkus; Paula K Greer; Huishan Zhu; Roger E McLendon; Darell D Bigner; Yiping He; Hai Yan
Journal:  Cancer Res       Date:  2017-09-22       Impact factor: 12.701

4.  Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line.

Authors:  Maria Podbielska; Zdzisław M Szulc; Ewa Kurowska; Edward L Hogan; Jacek Bielawski; Alicja Bielawska; Narayan R Bhat
Journal:  J Lipid Res       Date:  2016-09-13       Impact factor: 5.922

5.  Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation.

Authors:  Hui-Ling Chen; Li-Jin Chew; Roger J Packer; Vittorio Gallo
Journal:  Cancer Lett       Date:  2013-03-06       Impact factor: 8.679

6.  ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.

Authors:  Lin Qi; Zhong-Yong Wang; Xin-Rong Shao; Miao Li; Shu-Na Chen; Xue-Qi Liu; Shi Yan; Bo Zhang; Xu-Dong Zhang; Xin Li; Wenxue Zhao; Ji-An Pan; Bo Zhao; Xing-Ding Zhang
Journal:  Oncogene       Date:  2020-08-04       Impact factor: 9.867

7.  Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons.

Authors:  John P Kilkus; Rajendra Goswami; Sylvia A Dawson; Fernando D Testai; Eugeny V Berdyshev; Xianlin Han; Glyn Dawson
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

8.  Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress.

Authors:  Jingdong Qin; Rajendra Goswami; Sylvia Dawson; Glyn Dawson
Journal:  J Neurosci Res       Date:  2008-08-15       Impact factor: 4.164

Review 9.  Multiple system atrophy: experimental models and reality.

Authors:  Cassia Overk; Edward Rockenstein; Elvira Valera; Nadia Stefanova; Gregor Wenning; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2017-10-20       Impact factor: 17.088

10.  The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity.

Authors:  Jingdong Qin; John Kilkus; Glyn Dawson
Journal:  Biochim Biophys Acta       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.